HESA Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Notice of meeting Amended
Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting 112
Thursday, September 27, 2018, 8:45 a.m. to 10:45 a.m.
8:45 a.m. to 9:00 a.m.
(In Camera)Amended
(Public)
Witnesses
9:00 a.m. to 9:45 a.m.
Department of Health
• Catherine Parker, Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch
• Karen Reynolds, Executive Director, Office of Pharmaceuticals Management Strategies
• Dr. John Patrick Stewart, Director General, Therapeutic Products Directorate
9:45 a.m. to 10:45 a.m.
Amyotrophic Lateral Sclerosis Society of Canada
• Tammy Moore, Chief Executive Officer
Canadian Organization for Rare Disorders
• Maureen Smith, Board Secretary
• Durhane Wong-Rieger, President and Chief Executive Officer
Clerk of the Committee
Marie-Hélène Sauvé (613-995-4108)
2018-09-26 2:08 p.m.